Antagonist binding to the α2 noradrenaline receptor induces noradrenaline release. Binding of an antagonist to the noradrenaline receptor prevents binding of noradrenaline or of an agonist to the receptor and prevents secondary messenger inhibition allowing cell depolarization to occur.
Related content
This slide deck summarizes the current knowledge surrounding the use of psychedelics for the treatment of depression. Specifically, our focus centers on serotonergic psychedelics, commonly referred to as classical psychedelics. These psychedelics primarily function as agonists or partial agonists at the serotonin 2A receptor (5-HT2A receptor).
The infographic shows a 27% increase in depression cases due to COVID-19, affecting 280 million people worldwide.
Dr. Jasmina Mallet highlights the latest research in psychiatric genetics, emphasizing the role of Polygenic Risk Scores (PRS) in psychiatry.